Submission Science KO DMAA+DMHA Round 2 - GIGACULT

Product guide · Restricted substance

Submission Science KO Round 2

Submission Science

Stimulant formula from Submission Science. This guide sets out what the manufacturer states about the composition of Submission Science KO Round 2, what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.

Educational guide · Sources checked 4 November 2026 · 26 references

Back to the product
Named ingredients
15
Amounts stated
None
Status
Restricted substance
Evidence summaries
11

Overview

Manufacturer information

Ingredients & composition

Manufacturer information
IngredientAmount
DMAANot stated
DMHANot stated
HigenamineNot stated
YohimbineNot stated
Caffeine citrateNot stated
Synephrine HClNot stated
N-acetyl tyrosineNot stated
Huperzia serrataNot stated
Methylliberine (Dynamine®)Not stated
Citrulline malateNot stated
AGmassNot stated
VASO6Not stated
Schisandra chinensisNot stated
Vitamin B12Not stated
Vitamin D3Not stated

The manufacturer does not state the amount of any ingredient. Without amounts, the research summarised in this guide cannot be related to this product's dose.

Not covered in detail in this guide: Huperzia serrata, AGmass, VASO6, Schisandra chinensis.

Scientific background

Independent research

DMAA (1,3-dimethylamylamine)

DMAA (1,3-dimethylamylamine, methylhexanamine) is a synthetic stimulant that constricts blood vessels and raises blood pressure. It has been sold in pre-workout and weight-loss supplements and as a recreational stimulant1.

DMHA (2-aminoisoheptane, octodrine) and DMBA

DMHA, also labelled 2-aminoisoheptane or octodrine (2-amino-6-methylheptane), is a synthetic aliphatic amine stimulant found in pre-workout and weight-loss supplements, sometimes alongside the related compound DMBA2.

Higenamine

Higenamine is a plant alkaloid that stimulates β2-adrenergic receptors, the same receptor family targeted by asthma bronchodilators. It is found in plants such as Nandina domestica3.

Yohimbine (yohimbe bark, rauwolscine)

Yohimbine is an alkaloid from the bark of the African tree Pausinystalia yohimbe. It blocks α2-adrenergic receptors, which increases noradrenaline release. Rauwolscine (alpha-yohimbine) is a closely related alkaloid.

Caffeine

Caffeine is a stimulant that blocks adenosine receptors in the brain, reducing perceived effort and fatigue. It is found in coffee, tea and energy drinks and is a common ingredient in pre-workout products4.

Dicaffeine malate (sold as Infinergy®) is caffeine bonded to malic acid. Its caffeine adds to the total caffeine in a product, but labels do not always state the caffeine equivalent.

Synephrine (bitter orange, Citrus aurantium)

p-Synephrine is the main protoalkaloid of bitter orange (Citrus aurantium). It is structurally related to adrenaline and is used in weight-loss and pre-workout products5.

L-tyrosine

L-tyrosine is an amino acid that the body uses to make the neurotransmitters dopamine and noradrenaline. It is found in protein-rich foods; N-acetyl-L-tyrosine is a related form6.

Theacrine (TeaCrine®) and theobromine

Theacrine is a purine alkaloid related to caffeine, found in some tea plants; theobromine is the related methylxanthine in cocoa. Both are used in stimulant products.

L-citrulline and citrulline malate

L-citrulline is an amino acid that the body converts to arginine, a precursor of nitric oxide, which widens blood vessels. Citrulline malate combines citrulline with malic acid7.

Vitamin B12 (cobalamin)

Vitamin B12 is needed for red blood cell formation and nerve function. EFSA set an adequate intake of 4 µg a day for adults8. It is found almost only in animal foods, so vegans need a supplement or fortified foods.

Vitamin D3 (cholecalciferol)

Vitamin D is made in the skin in sunlight and is found in a few foods. It is needed for calcium absorption and bone health. EFSA set an adequate intake of 15 µg (600 IU) a day for adults9. 1 µg equals 40 IU.

Research evidence

Independent research

DMAA (1,3-dimethylamylamine)

No controlled trials show that DMAA improves athletic performance or weight loss. A pharmacokinetic study of a single 25 mg dose did not find meaningful changes in resting heart rate, blood pressure or body temperature10.

DMHA (2-aminoisoheptane, octodrine) and DMBA

There are no controlled human trials showing that DMHA improves exercise performance or weight loss.

Higenamine

There are no controlled human trials showing that higenamine improves exercise performance or weight loss. Analyses of US supplements found up to about 62 mg per serving, with labels that often did not state the amount3.

Yohimbine (yohimbe bark, rauwolscine)

A small trial in professional soccer players found reduced body fat with yohimbine but no change in body mass, muscle mass or performance11. Larger, independent trials are lacking.

Caffeine

The International Society of Sports Nutrition concludes that caffeine consistently improves exercise performance when consumed in doses of about 3–6 mg per kg of body mass, with benefits for muscular endurance, movement velocity, strength, sprinting, jumping and aerobic exercise4.

Synephrine (bitter orange, Citrus aurantium)

A review of human clinical studies reported small increases in energy expenditure and modest weight loss with bitter orange extract or p-synephrine products over 6–12 weeks, many in combination with other ingredients5.

L-tyrosine

A review found that tyrosine may support cognitive performance in short-term stressful or cognitively demanding situations, when these neurotransmitters are temporarily depleted, but found no consistent effect on physical exercise performance6.

Theacrine (TeaCrine®) and theobromine

An 8-week study of daily theacrine (TeaCrine®) up to 300 mg a day reported no safety concerns and no tolerance effect12. Evidence for performance benefits is limited.

L-citrulline and citrulline malate

A review of human studies found that citrulline supplementation raises plasma arginine, and that several studies report improved exercise performance or recovery, but the results are inconsistent7.

Vitamin B12 (cobalamin)

Authorised EU claims include that vitamin B12 contributes to normal red blood cell formation, normal functioning of the nervous system and the reduction of tiredness and fatigue13.

Vitamin D3 (cholecalciferol)

Authorised EU claims include that vitamin D contributes to the maintenance of normal bones, muscle function and immune function13.

In the large VITAL trial, 2000 IU (50 µg) a day of vitamin D3 did not lower the incidence of invasive cancer or major cardiovascular events compared with placebo14. A meta-analysis found that vitamin D supplements did not prevent fractures or falls, or have clinically meaningful effects on bone density15.

Evidence limitations

Independent research

This product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.

The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.

DMAA (1,3-dimethylamylamine)

The single-dose study does not reflect repeated use, higher doses or combination with other stimulants and exercise10. Analyses of sports and weight-loss supplements have repeatedly found stimulants that were not declared, or quantities different from the label216.

DMHA (2-aminoisoheptane, octodrine) and DMBA

The research concerns detection of these stimulants in supplements, not their effects. Analyses of sports and weight-loss supplements have repeatedly found stimulants that were not declared, or quantities different from the label216.

Higenamine

Published research concerns supplement analysis rather than effects in humans3.

Yohimbine (yohimbe bark, rauwolscine)

Evidence for fat loss or performance is limited to small studies. Supplement labels are often inaccurate: of 49 US yohimbine supplements tested, only 2 gave accurate information on both the quantity and the known adverse effects17.

Caffeine

Responses vary widely between people, partly because of genetics and habitual caffeine use. Many studies use pure caffeine, so results do not automatically apply to multi-ingredient products4.

Synephrine (bitter orange, Citrus aurantium)

Most studies are small, short and use multi-ingredient products, and longer studies are needed to establish efficacy and safety5.

L-tyrosine

Most studies are small and use single doses in laboratory settings6.

Theacrine (TeaCrine®) and theobromine

Studies are few, small and often industry-funded12.

L-citrulline and citrulline malate

Studies differ in dose, form (citrulline or citrulline malate, often with an unverified ratio) and exercise test, and many are small. The mechanism behind any performance effect is not established7.

Vitamin B12 (cobalamin)

Extra benefit beyond correcting low status is not established.

Vitamin D3 (cholecalciferol)

Benefits are clearest for correcting deficiency. Trials in people with adequate vitamin D status show little benefit for bone, cancer or heart outcomes1415.

Safety & potential risks

Independent research

DMAA (1,3-dimethylamylamine)

DMAA is a potent pressor agent. Cases of cerebral haemorrhage have been reported in adults after using DMAA1.

DMHA (2-aminoisoheptane, octodrine) and DMBA

Human safety data are lacking. As a sympathomimetic amine, DMHA may raise heart rate and blood pressure; avoid combining it with other stimulants. Contaminated supplements have caused positive doping tests16.

Higenamine

As a β2-agonist, higenamine may raise heart rate and cause palpitations, and its safety at supplement doses has not been established3.

Yohimbine (yohimbe bark, rauwolscine)

A review of poison-centre cases found that adverse events with yohimbine products had more serious outcomes than average exposures, including rapid heart rate, anxiety, high blood pressure and agitation18. People with heart conditions, high blood pressure, anxiety disorders or taking antidepressants should not use yohimbine.

Caffeine

EFSA concluded that single doses of up to 200 mg, and daily intakes of up to 400 mg from all sources, do not raise safety concerns for healthy adults. For pregnant and breastfeeding women, daily intakes up to 200 mg do not raise concerns for the foetus or infant19.

Higher intakes can cause anxiety, sleep disturbance, raised heart rate and blood pressure, and digestive upset. Combining several caffeine sources (coffee, energy drinks, pre-workouts) raises total intake194.

Synephrine (bitter orange, Citrus aurantium)

The reviewed studies did not report serious adverse effects at the doses tested5, but combining synephrine with caffeine and other stimulants increases cardiovascular stress. People with high blood pressure, heart-rhythm disorders or taking stimulant or antidepressant medication should avoid it.

L-tyrosine

People taking MAO inhibitors or thyroid medication should not use tyrosine supplements without medical advice.

Theacrine (TeaCrine®) and theobromine

Combined with caffeine and other stimulants, these compounds add to the overall stimulant load19.

L-citrulline and citrulline malate

Citrulline is generally well tolerated in the doses studied. Digestive discomfort has been reported, and people taking blood-pressure or erectile-dysfunction medication should ask a doctor, because citrulline raises arginine and nitric oxide production7.

Vitamin B12 (cobalamin)

No tolerable upper intake level has been set, and adverse effects of high oral intakes have not been established20.

Vitamin D3 (cholecalciferol)

EFSA set a tolerable upper intake level of 100 µg (4000 IU) a day for adults, based on persistent hypercalciuria (excess calcium in the urine) as an early sign of excess vitamin D21. Long-term intakes above this level can raise blood calcium and harm the kidneys. High-dose products should only be used on medical advice.

Regulatory status

GIGACULT product information

Contains 1,3-dimethylamylamine (DMAA), a synthetic stimulant that is not authorised as a novel food in the EU and is on the WADA Prohibited List. Contains DMHA/DMBA, a synthetic stimulant that is not authorised as a novel food in the EU. Contains higenamine and/or octopamine, which are on the WADA Prohibited List. Contains yohimbine. Isolated yohimbine is classified as a medicinal substance in several EU member states; its legal status depends on the country of sale.

Regulation and sport

DMAA (1,3-dimethylamylamine)

DMAA is not authorised as food or as a food supplement ingredient in the EU22 and is prohibited in competition by the World Anti-Doping Agency223.

DMHA (2-aminoisoheptane, octodrine) and DMBA

DMHA and DMBA are not authorised as novel foods in the EU22. Octodrine and related stimulants are prohibited in competition by the World Anti-Doping Agency1623.

Higenamine

Higenamine is not an authorised food supplement ingredient in the EU22 and is prohibited at all times by the World Anti-Doping Agency as a β2-agonist1623.

Yohimbine (yohimbe bark, rauwolscine)

Yohimbine is a pharmacologically active substance. Its use in food is regulated under Regulation (EC) No 1925/2006 and national rules24, and several EU Member States treat it as a medicinal substance25.

Caffeine

Caffeine is permitted in EU foods and food supplements, subject to labelling rules. It is not on the World Anti-Doping Agency Prohibited List23.

Synephrine (bitter orange, Citrus aurantium)

Bitter orange extracts are used in EU food supplements under national rules, which differ between Member States26.

L-tyrosine

Amino acids such as L-tyrosine are used in EU food supplements under national rules. No health claim is authorised13.

Theacrine (TeaCrine®) and theobromine

Theacrine is not an authorised novel food in the EU22; theobromine occurs naturally in cocoa. No health claim for this ingredient is authorised in the EU13; botanical ingredients are sold under national food-supplement rules26.

L-citrulline and citrulline malate

L-citrulline is used in EU food supplements under national rules. No health claim for citrulline is authorised in the EU13.

Vitamin B12 (cobalamin)

It is a permitted nutrient in EU food supplements26; authorised claims may only be used in their approved wording and when the product is at least a source of the nutrient13.

Vitamin D3 (cholecalciferol)

It is a permitted nutrient in EU food supplements26; authorised claims may only be used in their approved wording and when the product is at least a source of the nutrient13.

Scientific references

  1. Gee P, Tallon C, Long N, et al. Use of recreational drug 1,3-dimethylamylamine (DMAA) associated with cerebral hemorrhage. Ann Emerg Med. 2012;60:431-434. PubMed 22575212
  2. Cohen PA, Travis JC, Keizers PHJ, et al. Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol (Phila). 2018;56:421-426. PubMed 29115866
  3. Cohen PA, Travis JC, Keizers PHJ, et al. The stimulant higenamine in weight loss and sports supplements. Clin Toxicol (Phila). 2019;57:125-130. PubMed 30188222
  4. Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18:1. PubMed 33388079
  5. Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012;9:527-538. PubMed 22991491
  6. Jongkees BJ, Hommel B, Kühn S, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands: a review. J Psychiatr Res. 2015;70:50-57. PubMed 26424423
  7. Gonzalez AM, Trexler ET. Effects of citrulline supplementation on exercise performance in humans: a review of the current literature. J Strength Cond Res. 2020;34:1480-1495. PubMed 31977835
  8. EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for cobalamin (vitamin B12). EFSA Journal. 2015;13:4150. DOI 10.2903/j.efsa.2015.4150
  9. EFSA NDA Panel. Dietary reference values for vitamin D. EFSA Journal. 2016;14:4547. DOI 10.2903/j.efsa.2016.4547
  10. Schilling BK, Hammond KG, Bloomer RJ, et al. Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men. BMC Pharmacol Toxicol. 2013;14:52. PubMed 24090077
  11. Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. 2006;14:289-299. PubMed 17214405
  12. Taylor L, Mumford P, Roberts M, et al. Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use. J Int Soc Sports Nutr. 2016;13:2. PubMed 26766930
  13. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. Source
  14. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33-44. PubMed 30415629
  15. Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6:847-858. PubMed 30293909
  16. Cohen PA, Travis JC, Vanhee C, et al. Nine prohibited stimulants found in sports and weight loss supplements. Clin Toxicol (Phila). 2021;59:975-981. PubMed 33755516
  17. Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8:357-369. PubMed 26391406
  18. Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother. 2010;44:1022-1029. PubMed 20442348
  19. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;13(5):4102. DOI 10.2903/j.efsa.2015.4102
  20. Scientific Committee on Food / EFSA. Tolerable Upper Intake Levels for Vitamins and Minerals. European Food Safety Authority; 2006. Source
  21. EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA Journal. 2023;21:8145. DOI 10.2903/j.efsa.2023.8145
  22. Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
  23. World Anti-Doping Agency. The Prohibited List (current edition). Source
  24. Regulation (EC) No 1925/2006 on the addition of vitamins and minerals and of certain other substances to foods. Official Journal of the European Union. Source
  25. Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
  26. Directive 2002/46/EC on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union. Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product

Submission Science KO Round 2

€49,90 · Sold out

View product